9091.5000 14.50 (0.16%)
NSE Dec 19, 2025 15:31 PM
Volume: 5,946
 

Business Standard
"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Soriot was quoted as saying
More from AstraZeneca Pharma India Ltd.
Recommended